Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Jorgensen Nathan D.
Chief Financial Officer at Voyager Therapeutics. Filing since 3 Oct 2025.
CIK 0001842523
Company
Date
Role
Action
Shares
Amount
Of holding
VYGR
Voyager Therapeutics, Inc.
24 Feb 2026
Chief Financial Officer
Sold on a plan
4,668
$17.60K
3.0%
VYGR
Voyager Therapeutics, Inc.
3 Oct 2025
Chief Financial Officer
Sold on a plan
7,666
$36.64K
5.8%
2 decisions on file.
